An important minority of prediabetic first-degree relatives of type 1 diabetic patients derives from seroconversion to persistent autoantibody positivity after 10 years of age

Islet Autoantibody Seroconversion in the DPT-1 Study: Justification for repeat screening throughout childhood

(2011) K. Vehik et al.   DIABETES CARE

Development of Autoantibodies in the TrialNet Natural History Study

(2011) K. Vehik et al.   DIABETES CARE

Stopping Type 1 Diabetes: Attempts to Prevent or Cure Type 1 Diabetes in Man

(2010) J. S. Skyler et al.   DIABETES

Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population

(2010) O. Simell et al.   DIABETES CARE

Prediction of Type 1 Diabetes in the General Population

(2010) M. Knip et al.   DIABETES CARE

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

(2010) B. Keymeulen et al.   DIABETOLOGIA

The Environmental Determinants of Diabetes in the Young (TEDDY) Study

(2009)   Annals of the New York Academy of Sciences

Novel antigens in type 1 diabetes: The importance of ZnT8

(2009) Janet M. Wenzlau et al.   Current Diabetes Reports

Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2β) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials

(2009) J. De Grijse et al.   DIABETOLOGIA

Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk

(2009) P. Achenbach et al.   DIABETOLOGIA

Clinical Applications of Diabetes Antibody Testing

(2009) Polly J. Bingley   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM